Literature DB >> 26595349

Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey.

Emmanuelle A D Schindler1, Christopher H Gottschalk1, Marsha J Weil2, Robert E Shapiro3, Douglas A Wright2, Richard Andrew Sewell4.   

Abstract

Cluster headache is one of the most debilitating pain syndromes. A significant number of patients are refractory to conventional therapies. The Clusterbusters.org medication use survey sought to characterize the effects of both conventional and alternative medications used in cluster headache. Participants were recruited from cluster headache websites and headache clinics. The final analysis included responses from 496 participants. The survey was modeled after previously published surveys and was available online. Most responses were chosen from a list, though others were free-texted. Conventional abortive and preventative medications were identified and their efficacies agreed with those previously published. The indoleamine hallucinogens, psilocybin, lysergic acid diethylamide, and lysergic acid amide, were comparable to or more efficacious than most conventional medications. These agents were also perceived to shorten/abort a cluster period and bring chronic cluster headache into remission more so than conventional medications. Furthermore, infrequent and non-hallucinogenic doses were reported to be efficacious. Findings provide additional evidence that several indoleamine hallucinogens are rated as effective in treating cluster headache. These data reinforce the need for further investigation of the effects of these and related compounds in cluster headache under experimentally controlled settings.

Entities:  

Keywords:  Internet survey; cluster headache; hallucinogens; lysergic acid amide; lysergic acid diethylamide; psilocybin

Mesh:

Substances:

Year:  2015        PMID: 26595349     DOI: 10.1080/02791072.2015.1107664

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  16 in total

1.  Analytical characterization of N,N-diallyltryptamine (DALT) and 16 ring-substituted derivatives.

Authors:  Simon D Brandt; Pierce V Kavanagh; Geraldine Dowling; Brian Talbot; Folker Westphal; Markus R Meyer; Hans H Maurer; Adam L Halberstadt
Journal:  Drug Test Anal       Date:  2016-04-21       Impact factor: 3.345

Review 2.  Clinical applications of hallucinogens: A review.

Authors:  Albert Garcia-Romeu; Brennan Kersgaard; Peter H Addy
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

Review 3.  The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.

Authors:  Matthew W Johnson; Roland R Griffiths; Peter S Hendricks; Jack E Henningfield
Journal:  Neuropharmacology       Date:  2018-06-05       Impact factor: 5.250

Review 4.  Potential Therapeutic Effects of Psilocybin.

Authors:  Matthew W Johnson; Roland R Griffiths
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

5.  Models of psychedelic drug action: modulation of cortical-subcortical circuits.

Authors:  Manoj K Doss; Maxwell B Madden; Andrew Gaddis; Mary Beth Nebel; Roland R Griffiths; Brian N Mathur; Frederick S Barrett
Journal:  Brain       Date:  2022-04-18       Impact factor: 15.255

Review 6.  Psychedelics in the Treatment of Headache and Chronic Pain Disorders.

Authors:  Emmanuelle A D Schindler
Journal:  Curr Top Behav Neurosci       Date:  2022

7.  Psychoactive substances as a last resort-a qualitative study of self-treatment of migraine and cluster headaches.

Authors:  Martin Andersson; Mari Persson; Anette Kjellgren
Journal:  Harm Reduct J       Date:  2017-09-05

Review 8.  Modern Clinical Research on LSD.

Authors:  Matthias E Liechti
Journal:  Neuropsychopharmacology       Date:  2017-04-27       Impact factor: 7.853

Review 9.  The Therapeutic Potential of Psilocybin.

Authors:  Henry Lowe; Ngeh Toyang; Blair Steele; Henkel Valentine; Justin Grant; Amza Ali; Wilfred Ngwa; Lorenzo Gordon
Journal:  Molecules       Date:  2021-05-15       Impact factor: 4.411

Review 10.  Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics.

Authors:  Emmanuelle A D Schindler; Ryan M Wallace; Jordan A Sloshower; Deepak C D'Souza
Journal:  Front Pharmacol       Date:  2018-03-01       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.